Related Experiment Video

Updated: Jul 28, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

Neuropsychological test patterns in men for Alzheimer's and multi-infarct dementia

E W Russell1, D Polakoff

  • 1Veterans Administration Medical Center, Miami, Florida 33125, USA.

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|July 1, 1993
PubMed

Insights

This study found that specific patterns on the Halstead Reitan Battery (HRB) effectively differentiated Alzheimer's Disease (AD) from Multi-Infarct Dementia (MID) in male patients. HRB formulas achieved 92% accuracy, outperforming WAIS-R and Fuld formulas in diagnosing dementia types.

Area of Science:

  • Neuropsychology
  • Neurology
  • Gerontology

Background:

  • Differentiating Alzheimer's Disease (AD) from cerebrovascular disease, particularly Multi-Infarct Dementia (MID), is crucial for accurate diagnosis and treatment.
  • Cognitive assessment tools like the Halstead Reitan Battery (HRB) and Wechsler Adult Intelligence Scale-Revised (WAIS-R) are used to evaluate cognitive impairment.

Purpose of the Study:

  • To investigate distinct performance patterns on the HRB and WAIS-R that can differentiate AD from MID.
  • To evaluate the efficacy of existing formulas, including Fuld's formula, and derive new ones for improved diagnostic accuracy.

Main Methods:

  • Employed three studies with male subjects, equating for severity of impairment.
  • Administered the HRB and WAIS-R to groups of AD and transient ischemic attack (TIA) subjects (Studies 1 & 2).
  • Applied derived HRB and WAIS-R formulas to a new sample of AD and MID subjects (Study 3).

Main Results:

  • A specific WAIS-R deterioration pattern identified AD subjects with 84% accuracy; Fuld's formula achieved 76% accuracy.
  • HRB formulas demonstrated higher diagnostic power, correctly identifying approximately 92% of subjects, with motor tests showing less impairment in AD.
  • HRB formulas maintained high separation rates in the independent sample, while WAIS-R and Fuld formulas did not reach statistical significance in the third study.

Conclusions:

  • The HRB, particularly its motor components, shows significant potential in differentiating AD from MID.
  • HRB-derived formulas offer superior diagnostic accuracy compared to WAIS-R and Fuld formulas for distinguishing between AD and MID.
  • Further validation is needed for WAIS-R and Fuld formulas in distinguishing AD from MID in independent samples.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...